The problem: Almost all gene expression methods are sensitive to unavoidable variation in gene delivery, generating broad distributions of protein expression across individual cells. This variability complicates downstream analysis in experiments. It is also a problem in gene therapy for dosage-sensitive diseases like Rett syndrome, where both too little or too much expression of the therapeutic gene causes disease.
What is needed is a compact, protein-free, “plug and play” system that can compensate for gene dosage variability to achieve a defined, but tunable, set-point for transgene expression.